当前位置:首页 - 行情中心 - 羚锐制药(600285) - 财务分析

羚锐制药

(600285)

  

流通市值:123.42亿  总市值:123.69亿
流通股本:5.66亿   总股本:5.67亿

羚锐制药(600285)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润2.47亿元,每股收益0.44元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益368532.54万元,未分配利润239855.49万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产596568.48万元,负债228035.94万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入1,126,074,496.053,853,391,129.73,041,361,639.172,099,205,515.81
营业总成本848,497,974.233,029,670,519.082,332,076,667.211,580,082,239.98
其他经营收益
营业利润285,253,602.85887,273,905.67758,364,587.13551,471,072.75
利润总额285,511,916.89879,465,631.28757,558,792.81551,547,542.75
净利润247,441,910.98762,447,855.85653,536,523.2475,868,499.88
每股收益
其他综合收益-71,032.4542,390,202.714,885,283.796,235,719.57
综合收益总额247,370,878.53804,838,058.56658,421,806.99482,104,219.45
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,566,464,708.692,279,888,243.922,574,106,317.52,346,584,704.86
非流动资产:
非流动资产合计3,399,220,128.593,355,618,696.343,181,581,407.383,225,642,764.74
资产总计5,965,684,837.285,635,506,940.265,755,687,724.885,572,227,469.6
流动负债:
流动负债合计2,191,225,278.112,115,579,452.252,393,537,389.612,393,949,476.05
非流动负债:
非流动负债合计89,134,126.9184,013,302.5178,865,018.2377,969,701.15
负债合计2,280,359,405.022,199,592,754.762,472,402,407.842,471,919,177.2
所有者权益(或股东权益):
归属于母公司股东权益合计3,648,870,888.173,400,583,878.893,248,239,730.073,066,393,164.32
股东权益合计3,685,325,432.263,435,914,185.53,283,285,317.043,100,308,292.4
负债和股东权益合计5,965,684,837.285,635,506,940.265,755,687,724.885,572,227,469.6
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,048,573,124.13,925,891,376.753,108,738,229.972,069,419,931.08
经营活动现金流出小计780,122,968.493,372,008,662.962,618,350,573.611,713,832,424.33
经营活动产生的现金流量净额268,450,155.61553,882,713.79490,387,656.36355,587,506.75
投资活动产生的现金流量:
投资活动现金流入小计432,522,777.321,493,318,038.35722,196,602.94194,001,683.84
投资活动现金流出小计531,131,261.232,679,444,946.961,916,478,880.541,122,660,675.1
投资活动产生的现金流量净额-98,608,483.91-1,186,126,908.61-1,194,282,277.6-928,658,991.26
筹资活动产生的现金流量:
筹资活动现金流入小计64,245,955.83371,250,790.47517,374,558.27398,070,362.29
筹资活动现金流出小计164,028,641584,513,307.64582,179,320.3521,038,763.95
筹资活动产生的现金流量净额-99,782,685.17-213,262,517.17-64,804,762.03-122,968,401.66
汇率变动对现金及现金等价物的影响-9,302.68-27,150.54-22,131.92-18,920.46
现金及现金等价物净增加额70,049,683.85-845,533,862.53-768,721,515.19-696,058,806.63
期末现金及现金等价物余额452,893,627.32382,843,943.47459,656,290.81532,318,999.37
补充资料:
现金及现金等价物的净增加额--845,533,862.53--696,058,806.63
最新报告期:2026-05-12
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
长城证券刘鹏,袁紫馨1.541.751.962026-05-12
首创证券王斌1.501.722.002026-05-08
中信建投袁全,刘若飞,沈兴熙,贺菊颖1.521.721.942026-05-08
信达证券唐爱金,章钟涛1.531.731.972026-04-30
开源证券余汝意,巢舒然1.521.701.922026-04-30
TOP↑